Characterization of the myelotoxicity of chloramphenicol succinate in the B6C3F1 mouse

International Journal of Experimental Pathology

Volumn 87, Issue 2, 2006, Pages 101-112

  Turton, John A ^a   Fagg, Rajni ^b   Sones, William R ^a,c   Williams, Thomas C ^b   Andrews, C Michael ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Chloramphenicol; Haemotoxicity; Mouse; Myelotoxicity; Reticulocyte; Spleen

Indexed keywords

CHLORAMPHENICOL HEMISUCCINATE;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD TOXICITY; BONE MARROW; BONE MARROW TOXICITY; BURST FORMING UNIT E; CELL REGENERATION; CELL VACUOLE; CLONOGENIC ASSAY; COLONY FORMING UNIT E; CYTOPENIA; DRUG MEGADOSE; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; FLUORESCENCE ANALYSIS; LEUKOCYTE; LEUKOPENIA; MOUSE STRAIN; NONHUMAN; PANCYTOPENIA; PRIORITY JOURNAL; RETICULOCYTE COUNT; SPLEEN; SPLEEN CELL; STEM CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BONE MARROW; BONE MARROW CELLS; CELL COUNT; CHLORAMPHENICOL; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTES; FEMALE; LEUKOCYTES; MICE; MICE, INBRED STRAINS; RETICULOCYTES; SPLEEN; STEM CELLS;

EID: 33645352522     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2006.00460.x     Document Type: Article

References (76)

1. Adams P. 1983 Chloramphenicol-responsive chronic neutropenia. N. Engl. J. Med. 309, 1039 1041.
2. Anagnostou A. Zander A. Barone J. Fried W. 1976 Mechanisms of the increased splenic erythropoiesis in mice treated with estradiol benzoate. J. Lab. Clin. Med. 88, 700 706.
3. Andrews C.M. 1995 Sensitivity of reticulocyte high fluorescence ratio to splenic erythropoiesis. Comp. Haematol. Int. 5, 210.
4. Andrews C.M. 2000 Studies on the haemotoxicity of busulphan and chloramphenicol in the B6C3F1 mouse. PhD Thesis. University of London.
5. Andrews C.M. Dash L.M. Williams T.C. Criag Gray J. Turton J.A. 1997 Long-term effects of busulphan on lymphocyte subpopulations in female B6C3F1 mice. Comp. Haematol. Int. 7, 230 237.
6. Andrews C.M. Spurling N.W. Turton J.A. 1993 Characterisation of busulphan-induced myelotoxicity in B6C3F1 mice using flow cytometry. Comp. Haematol. Int. 3, 102 115.
7. Andrews C.M. Williams T.C. Turton J.A. 1998 Long-term haematological alterations in female B6C3F1 mice treated with busulphan. Comp. Haematol. Int. 8, 125 138.
8. Benestad H. 1979 Drug mechanisms in marrow aplasia. In: Aplastic Anaemia, pp. 26 42 Geary C.G.. London Balliere-Tindall.
9. Bentley S.A. Taylor M.A. Killian D.E. et al. 1995 Correction of bone marrow nucleated cell counts for the presence of fat particles. Am. J. Clin. Pathol. 104, 60 64.
10. Best W.R. 1967 Chloramphenicol-associated blood dyscrasias. J. Am. Med. Assoc. 201, 99 106.
11. Bostrom B. Smith K. Ramsey N.K.C. 1986 Stimulation of human committed bone marrow stem cells (CFU-GM) by chloramphenicol. Exp. Haematol. 14, 156 161.
12. Chaplin S. 1986 Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol-part II. Adverse Drug React. Acute Poisoning Rev. 3, 181 196.
13. Dacie J.V. Lewis S.M. 1975 Practical Haematology 5th edn. London Churchill Livinstone.
14. Davies D.T. Fisher G.V. 1991 The evaluation and application of the Techicon H*1 for the complete automated evaluation of laboratory animal haematology. Comp. Haematol. Int. 1, 803 808.
15. Dollery C. 1999 Therapeutic Drugs. Edinburgh Churchill Livingstone.
16. FAO/WHO 1988 Expert on food additives. Chloramphenicol. In: Toxicological Evaluation of Certain Veterinary Drug Residues in Food (WHO Food Additives Series 23) 1 71. Geneva World Health Organization.
17. Ferrari V. Pajola E. 1981 Types of haemopoietic inhibition by chloramphenicol and thiamphenicol. In: Safety Problems Related to Chloramphenicol and Thiamphenicol, pp. 43 59 (eds. Najean Y. Tognoni G. Yunis A.A.. New York Raven Press.
18. Festing M.F.W. Diamanti P. Turton J. 2001 Strain differences in haematological response to chloramphenicol succinate in mice: implications for toxicological research. Food Chem. Toxicol. 39, 375 383.
19. Filmanowicz E. Gurney C.W. 1960 Studies on erythropoiesis XV1. Response to a single dose of erythropoietin in polycythemic mice. J. Lab. Clin. Med. 57, 65 72.
20. Fraunfelder F.T. Morgan R.L. Yunis A.A. 1993 Blood dyscrasias and topical ophthalmic chloramphenicol. Am. J. Ophthalmol. 115, 812 813.
21. Freeman K.P. 2000 Bone marrow evaluation. In: Schalm's Veterinary Haematology 5th edn, pp. 29 32 (eds. Feldman B.F. Zinkl J.G. Jain N.C.. Philadelphia Lippincott Williams.
22. Fuchs A. Eder H. 1991 Automated reticulocyte analysis of blood in different species. Sysmex J. Int. 1, 34 38.
23. Goris H. Bungart B. Loeffler M. Schmitz S. Nijhof W. 1990 Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice. Exp. Haematol. 18, 400 407.
24. Haak H.L. 1980 Experimental drug-induced aplastic anaemia. Clinics Haematol. 9, 621 639.
25. Hall R. Malia R.G. 1984 Medical Laboratory Haematology. London Butterworths.
26. de Hann G. Loeffler M. Nijhof W. 1992 Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anaemia. Exp. Haematol. 20, 600 604.
27. Havard A. Andrews M. Holt D. Williams T. Turton J.A. 1999a Chloramphenicol-induced reticulocytopenia and anaemia in the mouse: depressed parameters return to normal with continued dosing. Hum. Exp. Toxicol. 18, 532.
28. Havard A. Andrews C.M. Willliams T.C. Turton J.A. 1999b Chloramphenicol induces reversible dose-related reticulocytopenia, not aplastic anaemia, in the guinea pig. Hum. Exp. Toxicol. 18, 764.
29. Heimpel H. 2000 Epidemiology and etiology of aplastic anaemia. In: Aplastic Anaemia; Pathophysiology and Treatment, pp. 97 116 (eds. Schrezenmeier H. Bacigalupo A.. Cambridge Cambridge University Press.
30. 1 mouse. Hum. Exp. Toxicol. 17, 8 17.
31. Holt D. Harvey D. Hurley R. 1993 Chloramphenicol toxicity. Adverse Drug React. Toxicol. Rev. 12, 83 95.
32. Hugley C.M. Erslev A.J. Bergsagel D.E. 1961 Drug related blood dyscrasias. J. Am. Med. Assoc. 177, 23 26.
33. Hunt P. 1995 A bipotential megakaryocyte/erythrocyte progenitor cell: the link between erythropoiesis and megakaryopoiesis becomes stronger. J. Lab. Clin. Med. 125, 303 304.
34. IARC 1990 Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Chloramphenicol Vol. 50, pp. 169 193. Lyon IARC.
35. Jackson C.W. Simone J.V. Edwards C.C. 1974 The relationship of anaemia and thrombocytosis. J. Lab. Clin. Med. 84, 357 368.
36. Jandl H. 1996 Blood; Textbook of Haematology. Boston : Little Brown.
37. Jiji R.M. Gangarosa E.J. De la Macorra F. 1963 Chloramphenicol and its sulfamoyl analogue. Arch. Intern. Med. 111, 116 127.
38. Kinsey S.E. Watts M.J. 1988 Accurate automated leucocyte differential counts despite profound leucopemia. J. Clin. Pathol. 41, 1236 1239.
39. Klassen L.W. Birks J. Allen E. Gurney C.W. 1972 Experimental medullary aplasia. J. Lab. Clin. Med. 80, 8 17.
40. Knoll J.S. 2000 Clinical automated haematology systems. In: Schalm's Veterinary Haematology 5th edn, pp. 3 11 (eds. Feldman B.F. Zinkl J.G. Jain N.C.. Philadelphia Lippincott William.
41. Krakoff I.H. Karnofsky D.A. Burchenal J.H. 1955 Effects of large doses of chloramphenicol on human subjects. N. Engl. J. Med. 253, 7 10.
42. Kumar P. Verma I.C. 1993 Antibiotic therapy for bacterial meningitis in children in developing countries. Bull. Wld. Hlth. Org. 71, 183 188.
43. Kushwaha K.P. Verma R.B. Singh Y.D. Rathi A.K. 1994 Surveillance of drug induced diseases in children. Indian J. Pediatr. 61, 357 365.
44. Lee M. Durch S. Dale D. Finch C. 1979 Kinetic of tumour-induced murine neutrophilia. Blood 53, 619 632.
45. Miura A.B. Yoshida K. Yamaguchi A. Fukuda M. 1980 The effect of chloramphenicol and thiamphenicol on the ultrastructive of erythroblasts in mouse splenic colonies. Tohuku J. Exp. Med. 130, 335 340.
46. Morley A. Blake J. 1974a An animal model of chronic hypoplastic marrow failure. Late marrow failure after busulphan. Blood 44, 49 56.
47. Morley A. Blake J. 1974b Hemopoietic precursor cells in experimental hypoplastic marrow failure. Aust. J. Exp. Biol. Med. Sci. 52, 909 914.
48. Morley A. Trainor K. Blake J. 1975 A primary stem cell lesion in experimental chronic hypoplastic marrow failure. Blood 45, 681 688.
49. Morley A. Trainor K. Remes J. 1976 Residual marrow damage: possible explanation for idiosyncrasy to chloramphenicol. Br. J. Haematol. 32, 525 531.
50. Parfitt K. 1999 Martindale: the Complete Drug Reference 32nd edn., pp. 182 184. London Pharmaceutical Press.
51. Rich M.L. Ritterhoff R.J. Hoffmann R.J. 1950 A fatal case of aplastic anaemia following chloramphenicol (chloromycetin) therapy. Ann. Intern. Med. 33, 1459 1467.
52. Rigdon R.H. Crass G. Martin N. 1954 Anaemia produced by chloramphenicol (chloromycetin) in the duck. A. M. A. Arch. Pathol. 58, 85 93.
53. Rosenbach L.M. Caviles A.P. Mitus W.J. 1960 Chloramphenicol toxicity: reversible vacuolization of erythroid cells. N. Engl. J. Med. 263, 274 278.
54. Rubin D. Weisberger A.S. Botti R.E. Storaosli J.P. 1958 Changes in iron metabolism in early chloramphenicol toxicity. J. Clin. Invest. 37, 1286 1292.
55. Saidi M.D. Wallerstein R.O. Aggeler P.M. 1961 Effect of chloramphenicol on erythropoiesis. J. Lab. Clin. Med. 57, 247 256.
56. Sakaguchi M. Kawakita M. Matsushita J. Shibaya K. Koishihara Y. Takatsuki K. 1987 Human erythropoietin stimulates murine megakarypoiesis in serum-free culture. Exp. Haematol. 15, 1028 1034.
57. Schrober R. Kosek J.C. Wolf P.L. 1972 Chloramphenicol-induced vacuoles. Their ultrastructure in bone marrow pronormoblasts and immature myeloid cells. Arch. Pathol. 94, 298 392.
58. Scott J.L. Finegold S.M. Belkin G.A. Lawrence J.S. 1965 A controlled double blind study of the haematologic toxicity of chloramphenicol. N. Engl. J. Med. 272, 1137 1142.
59. Skinnider L.F. Ghadially F.N. 1976 Chloramphenicol-induced mitochondrial and ultrastructural changes in haemopoietic cells. Arch. Pathol. Lab. Med. 100, 601 605.
60. Smith C.A. Andrews C.M. Collard J.K. Hall D.E. Walker A.K. 1994 A Color Atlas of Comparative Diagnostic and Experimental Haematology. London Wolfe.
61. Tichelli A. Gratwohl A. Driessen A. et al. 1990 Evaluation of the SysmexR-1000: an automated reticulocyte analyser. Am. J. Clin. Pathol. 93, 70 78.
62. Trevett A.J. Naraqi S. Wambri J. 1992 Typhoid fever complicated by chloramphenicol toxicity, ataxia and psychosis. Papua New Guinea Med. J. 35, 205 209.
63. Turton J.A. Andrews C.M. Havard A.C. et al. 2002 Haemotoxicity of thiamphenicol in the BALB/c mouse and Wistar Hanover rat. Food Chem. Toxicol. 40, 1849 1861.
64. Turton J.A. Andrews C.M. Havard A.C. Williams T.C. 2003 Studies on the haemotoxicity of chloramphenicol in the Dunkin Hartley guinea pig. Int. J. Exp. Pathol. 83, 1 14.
65. Turton J.A. Havard A.C. Robinson S. et al. 2000 An assessment of chloramphenicol and thiamphenicol in the induction of aplastic anaemia in the BALB/c mouse. Food Chem. Toxicol. 38, 925 938.
66. Turton J.A. Yallop D. Andrews M. Fagg R. York M. Willaims T.C. 1999 Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover rat. Hum. Exp. Toxicol. 18, 566 576.
67. Vincent P.C. 1984 In vitro evidence of drug action in aplastic anaemia. Blut 49, 3 12.
68. Volini I.F. Greenspan L. Ehrlich L. Gunner J.A. Felsenfeld O. Schwartz S.O. 1950 Hemopoietic changes during administration of chloramphenicol (chloromycetin). J. Am. Med. Assoc. 142, 1333 1355.
69. Wallerstein R.O. Condit P.K. Kasper C.K. Brown J.W. Morrison F.R. 1969 Statewide study of chloramphenicol therapy and fatal aplastic anaemia. J. Am. Med. Assoc. 208, 2045 2050.
70. Welch H. Lewis C.N. Kerlan I. 1954 Blood dyscrasias. A nationwide survey. Antibiot. Chemother. 4, 607 623.
71. Young N.S. Alter B.P. 1994 Aplastic Anaemia: Acquired and Inherited. Philadelphia W.B. Saunders.
72. Young N.S. Maciejewski J.P. 1997 The pathophysiology of acquired aplastic anaemia. N. Engl. J. Med. 336, 1365 1372.
73. Young N.S. Maciejewski J.P. 2000 Aplastic anaemia. In: Haematology: Basic Principles and Practice, pp. 297 331 Hoffman. R. et al.. New York Churchill Livingstone.
74. Yunis A.A. 1978 Mechanisms underlying marrow toxicity from chloramphenicol and thiamphenicol. In: The Year in Haematology, pp. 143 170 (eds. Silver R. Le Bue J. Gordon A.S.. New York Plenum Press.
75. Yunis A.A. Bloomberg G.R. 1964 Chloramphenicol toxicity, clinical features and pathogenesis. Prog. Haematol. 4, 138 159.
76. Yunis A.A. Smith U.S. Restreppo A. 1970 Reversible bone marrow suppression from chloramphenicol: a consequence of mitochondrial injury. Arch. Intern. Med. 126, 272 275.